Registered entities
REGENERON PHARMACEUTICALS INC
Reg. No. 872589United States
Regeneron Pharmaceuticals, Inc.
Reg. No. 133444607United States
Regeneron Pharmaceuticals, Inc.
Reg. No. 001t000000WndtbAABUnited States
Regeneron Pharmaceuticals
Reg. No. -Belgium
REGENERON INDIA PRIVATE LIMITED
CIN U72900KA2022FTC160799India
Innovation
29 patent families (15 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 557 times.
| Year | Filings |
|---|---|
| 2022 | 1 |
| 2025 | 5 |
| 2026 | 23 |
Investor mix
9 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 33% |
| Private equity | 4 | 44% |
| Other / undisclosed | 2 | 22% |
Hiring activity
Hires frequently
76 roles tracked across 7 of the last 12 months
29 May 2026 · Senior Manager, Product Management - Delivery & Operations Product Lead · Warren
27 May 2026 · Senior Manager, Product Manager - Delivery & Operations Product Lead – Enabling Technologies · Warren
15 May 2026 · Associate Director Statistical Programming - Pharmacometrics · Warren
11 May 2026 · Medical Specialist II-Ophthalmology-Denver · Denver
9 May 2026 · Assoc Director Medical Communications - Switzerland · Basel
Based on job postings tracked across public sources.